Bronte Capital Management Pty Ltd. has filed its 13F form on May 13, 2025 for Q1 2025 where it was disclosed a total value porftolio of $944 Million distributed in 26 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ishares Core S&P Sm Cap ETF with a value of $136M, Berkshire Hathaway Inc Class B with a value of $116M, Regeneron Pharmaceuticals, Inc. with a value of $98.1M, Interactive Brokers Group, Inc. with a value of $87.2M, and Philip Morris International Inc. with a value of $82.3M.

Examining the 13F form we can see an decrease of $40.6M in the current position value, from $984M to 944M.

Below you can find more details about Bronte Capital Management Pty Ltd. portfolio as well as his latest detailed transactions.

Portfolio value $944 Million
Financial Services: $294 Million
ETFs: $169 Million
Communication Services: $130 Million
Consumer Defensive: $124 Million
Healthcare: $98.1 Million
Consumer Cyclical: $78.2 Million
Basic Materials: $41.3 Million
Technology: $9.2 Million
Other: $0

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 26
  • Current Value $944 Million
  • Prior Value $984 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 13, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 2 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 21 stocks
Track This Portfolio

Track Bronte Capital Management Pty Ltd. Portfolio

Follow Bronte Capital Management Pty Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bronte Capital Management Pty Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Bronte Capital Management Pty Ltd. with notifications on news.